About Secretome Therapeutics
Secretome Therapeutics is a company based in Dallas (United States) founded in 2018 by Sunjay Kaushal.. Secretome Therapeutics has raised $21.9 million across 2 funding rounds. Secretome Therapeutics offers products and services including STM-01 and STM-21. Secretome Therapeutics operates in a competitive market with competitors including AskBio, Calliditas Therapeutics, Inotrem, Enyo Pharma and Mesoblast, among others.
- Headquarter Dallas, United States
- Founders Sunjay Kaushal
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Secretome Therapeutics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$21.9 M (USD)
in 2 rounds
-
Latest Funding Round
$20.4 M (USD), Series B
Nov 25, 2024
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Secretome Therapeutics
Secretome Therapeutics offers a comprehensive portfolio of products and services, including STM-01 and STM-21. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug derived from nCPCs for treating heart failure and related conditions.
Secretome from nCPCs aimed at regenerative cardiovascular therapies.
Unlock access to complete
Unlock access to complete
Scientific Team
5 people
Leadership Team
4 people
Operations Team
2 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Secretome Therapeutics
Secretome Therapeutics has successfully raised a total of $21.9M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $20.4 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $20.4M
-
First Round
First Round
(17 Oct 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series B - Secretome Therapeutics | Valuation |
investors |
|
| Oct, 2019 | Amount | Seed - Secretome Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Secretome Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Secretome Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Secretome Therapeutics Comparisons
Competitors of Secretome Therapeutics
Secretome Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AskBio, Calliditas Therapeutics, Inotrem, Enyo Pharma and Mesoblast, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Provider of small molecule based drug for inflammatory kidney disease
|
|
| domain | founded_year | HQ Location |
Developer of peptide immunotherapies for treating septic shock and acute myocardial infarction
|
|
| domain | founded_year | HQ Location |
Therapeutics are developed for diseases with impaired kidney function.
|
|
| domain | founded_year | HQ Location |
Biotherapeutics derived from proprietary adult stem cell-based technologies
|
|
| domain | founded_year | HQ Location |
Small molecule therapies for kidney diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Secretome Therapeutics
Frequently Asked Questions about Secretome Therapeutics
When was Secretome Therapeutics founded?
Secretome Therapeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Secretome Therapeutics located?
Secretome Therapeutics is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Who is the current CEO of Secretome Therapeutics?
Vinny Jindal is the current CEO of Secretome Therapeutics.
Is Secretome Therapeutics a funded company?
Secretome Therapeutics is a funded company, having raised a total of $21.9M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Oct 17, 2019.
What does Secretome Therapeutics do?
Secretome Therapeutics was founded in 2018 in Dallas, United States, within the biotechnology sector. Cell-based therapies targeting various diseases are developed, with operations focused on innovative treatments. Lead products include STM-21, designed to prevent inflammatory toxicities from cancer therapies like cisplatin-induced acute kidney injury, and STM-01, a therapy using neonatal mesenchymal stem cells to restore cardiac function following heart attacks.
Who are the top competitors of Secretome Therapeutics?
Secretome Therapeutics's top competitors include Juvenescence, AskBio and Mission Therapeutics.
What products or services does Secretome Therapeutics offer?
Secretome Therapeutics offers STM-01 and STM-21.